Abstract
To investigate possible cardiac manifestations of Chagas disease, we tested 97 Latinx patients with nonischemic cardiomyopathy in Houston, Texas, USA, for Trypanosoma cruzi infection. We noted a high prevalence of underdiagnosed infection and discrepant results in clinical diagnostic assays. Latinx cardiac patients in the United States would benefi t from laboratory screening for T. cruzi infection.
| Original language | English |
|---|---|
| Pages (from-to) | 1958-1960 |
| Number of pages | 3 |
| Journal | Emerging Infectious Diseases |
| Volume | 27 |
| Issue number | 7 |
| DOIs | |
| State | Published - Jul 2021 |
Bibliographical note
Publisher Copyright:© 2021 Centers for Disease Control and Prevention (CDC). All rights reserved.
Funding
This project was funded by the National Institutes of Health, National Institute of Allergy and Infectious
| Funders | Funder number |
|---|---|
| National Institutes of Health (NIH) | |
| National Institute of Allergy and Infectious Diseases | R21AI114877 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
ASJC Scopus subject areas
- Epidemiology
- Microbiology (medical)
- Infectious Diseases
Fingerprint
Dive into the research topics of 'Trypanosoma cruzi in nonischemic cardiomyopathy patients, houston, texas, usa'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver